We pursue

Innovation.

Our Quantra Vector technology is
leading innovation in all material industries
around the world.

See More

Our Company

“Quantra Vector,” a quantum nano dry grinding method developed by NPG Science, produces pure substances that have never existed on Earth before. This innovative technology does not involve the use of any chemical agents or additives in its process.

Preparation for FDA approval for generic pharmaceuticals

In the process of man­u­fac­tur­ing sam­ples for gener­ic drugs and health func­tion­al food for US FDA reg­is­tra­tion. Expect­ed com­ple­tion of reg­is­tra­tion by Feb­ru­ary 2024.

See More

Main Material Production in the Medical Field

Prepa­ra­tion for research on inno­v­a­tive arti­fi­cial bone and implant mate­ri­als with excel­lent bio­com­pat­i­bil­i­ty, and hair loss prod­ucts based on hair fol­li­cle gen­er­a­tion.

See More

Specialized Material in Industrial Fields

Research on var­i­ous mate­ri­als for mil­i­tary stealth coat­ings, sec­ondary bat­ter­ies, and next-gen­er­a­tion bat­tery devel­op­ment. Also study­ing min­er­al decom­po­si­tion and sep­a­ra­tion tech­nolo­gies.

See More

Brand Story

In Korea, “Com­pa­ny A” attempt­ed to reg­is­ter com­mon phar­ma­ceu­ti­cals and health func­tion­al foods pro­duced through a nan­otech­nol­o­gy method one step low­er than our tech­nol­o­gy with the FDA, but faced fail­ure in their attempts.

In con­trast, our com­pa­ny suc­cess­ful­ly applied for FDA reg­is­tra­tion of prod­ucts man­u­fac­tured using our Quantra Vec­tor tech­nol­o­gy, prov­ing the supe­ri­or­i­ty of our tech­nol­o­gy by gain­ing offi­cial reg­is­tra­tion in one go.

Our prod­ucts were not only reg­is­tered as approved phar­ma­ceu­ti­cals but also simul­ta­ne­ous­ly enlist­ed as health func­tion­al foods under the same code. This acknowl­edg­ment occurred due to our use of nat­ur­al ingre­di­ents apply­ing our nano-tech­nol­o­gy, cre­at­ing phar­ma­ceu­ti­cals and health func­tion­al foods that are side-effect-free and rec­og­nized as safe. At that time, the US FDA praised our man­u­fac­tur­ing tech­nol­o­gy as “an incom­pa­ra­ble and excel­lent tech­nol­o­gy.”

Fur­ther­more, we plan to com­plete FDA reg­is­tra­tion by Feb­ru­ary 2024 for an addi­tion­al four prod­ucts with com­plex func­tions tar­get­ing spe­cif­ic symp­toms. These four prod­ucts encom­pass enhance­ment and treat­ment for car­dio­vas­cu­lar func­tion, osteo­poro­sis treat­ment, improve­ment for renal dis­eases and dia­betes treat­ment, and improve­ment and treat­ment for neu­ro­log­i­cal dis­eases.

More­over, we’ve com­plet­ed ver­i­fi­ca­tion indi­cat­ing the poten­tial appli­ca­tion of this tech­nol­o­gy in var­i­ous advanced mate­ri­als across indus­tries. To lead the glob­al mar­ket in respec­tive fields, we are col­lab­o­rat­ing across sec­tors to progress our busi­ness.

Business Report & News

Development of Artificial Bones and Implant Materials

•
12/17/2023
•
business_EN
•
No Com­ments

Con­tract with a Spe­cial­ized Arti­fi­cial Bone Man­u­fac­tur­er and Invest­ment Agree­ment Cur­rent­ly, med­ical mate­ri­als relat­ed to arti­fi­cial bones and implants uti­lize mate­ri­als …

Export of Nano Pharmaceuticals

•
12/17/2023
•
business_EN
•
No Com­ments

Export­ing Semi-fin­ished Phar­ma­ceu­ti­cal Prod­ucts to China’s Guo­tai Phar­ma­ceu­ti­cal Com­pa­ny The pri­ma­ry raw mate­r­i­al for our phar­ma­ceu­ti­cal man­u­fac­tur­ing is pri­mar­i­ly derived from …

Supplying to Large US Retailers

•
12/17/2023
•
business_EN
•
No Com­ments

Sales of Our Nano Prod­ucts in Major US Retail­ers In response to the shift in the trend favor­ing nat­ur­al phar­ma­ceu­ti­cals over …

Research on Nano-processed Red Ginseng Products

•
12/17/2023
•
business_EN
•
No Com­ments

Estab­lish­ment of Indus­try-Acad­e­mia Col­lab­o­ra­tion SPC with Kyung Hee Uni­ver­si­ty In col­lab­o­ra­tion with Pro­fes­sor Yang Deok-chun from Kyung Hee Uni­ver­si­ty, a renowned …

The Quantra Vector technology has proven to be a milestone in surpassing the limitations of dry nano-processing without chemical use, enabling the direct nano-conversion of natural nutritional ingredients. We hope to widely apply this remarkable technology in the medical field, contributing to the development of various new and better pharmaceuticals such as new drugs and new substances for the health of people worldwide.

Pro­fes­sor David Yang

ESG Award in the Environment Category for CEO Il-woo,Seo

CEO Seo Ilwoo was hon­ored with the ESG Award on August 25, 2023, due to the high eval­u­a­tion from the South Kore­an gov­ern­ment for envi­ron­men­tal­ly friend­ly pro­duc­tion of advanced mate­ri­als using Quantra Vec­tor tech­nol­o­gy.

 

The award cer­e­mo­ny was host­ed by the Korea Ser­vice Indus­try Pro­mo­tion Agency and was spon­sored by 15 gov­ern­ment depart­ments, includ­ing the Min­istry of Plan­ning and Finance, Min­istry of Edu­ca­tion, Min­istry of For­eign Affairs, Min­istry of Pub­lic Admin­is­tra­tion and Secu­ri­ty, Min­istry of Envi­ron­ment, Min­istry of SMEs and Star­tups, Min­istry of Food and Drug Safe­ty, Nation­al Fire Agency, Seoul Met­ro­pol­i­tan Gov­ern­ment, and Jeol­lanam-do Province.

 

This eval­u­a­tion select­ed awardees through com­pre­hen­sive ver­i­fi­ca­tion process­es cov­er­ing a wide range of ESG issues, includ­ing human rights, labor, fair trade, con­sumer issues, com­mu­ni­ty engage­ment, and devel­op­ment.

 

Through this ESG award, our com­pa­ny has gained recog­ni­tion for the excel­lence of Quantra Vec­tor tech­nol­o­gy, enabling us to broad­en our busi­ness scope and estab­lish cred­i­bil­i­ty in the glob­al pro­duc­tion of supe­ri­or mate­ri­als.

See More

Location

Head Office
502, 327 Teheran-ro, Gang­nam-gu, Seoul

Research Insti­tute
207, Geum­san Build­ing, 750, Nation­al Assem­bly-daero, Yeongde­ung­po-gu, Seoul

Phone: +82–2‑782‑0198 FAX: +82–2‑782‑0199
E‑mail: globalcc@naver.com

Scroll to Top